Table of Content

1 Study Coverage
1.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Outlook 2018 VS 2024 VS 2034
1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size for the Year 2018-2034
1.2.2 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size for the Year 2018-2034
1.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Chimeric Antigen Receptor (CAR) T-Cell Therapy in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Dynamics
1.4.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Trends
1.4.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers
1.4.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Challenges
1.4.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Chimeric Antigen Receptor (CAR) T-Cell Therapy by Type
2.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment by Type
2.1.1 CD19-targeted
2.1.2 BCMA-targeted
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018, 2024 & 2034)
2.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2034)
2.4 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018, 2024 & 2034)
2.5 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2034)
3 Chimeric Antigen Receptor (CAR) T-Cell Therapy by Application
3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment by Application
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018, 2024 & 2034)
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2034)
3.4 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018, 2024 & 2034)
3.5 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2034)
4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Competitor Landscape by Company
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Company
4.1.1 Global Key Companies of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Ranked by Revenue (2024)
4.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Player (2018-2023)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Concentration Ratio (CR)
4.2.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Chimeric Antigen Receptor (CAR) T-Cell Therapy in 2024
4.2.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy Head office and Area Served
4.4 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Product and Application
4.5 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Company
4.7.1 Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy in United States, Ranked by Revenue (2024)
4.7.2 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Players (2021, 2024 & 2023)
5 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2018-2034)
5.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region: 2018-2023
5.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2024-2034)
6 Americas
6.1 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth 2018-2034
6.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type
6.2.1 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023)
6.2.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034)
6.2.3 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
6.3 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application
6.3.1 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023)
6.3.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034)
6.3.3 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
6.4 Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth 2018-2034
7.2 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type
7.2.1 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023)
7.2.2 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034)
7.2.3 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
7.3 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application
7.3.1 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023)
7.3.2 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034)
7.3.3 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
7.4 EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth 2018-2034
8.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type
8.2.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023)
8.2.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034)
8.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
8.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application
8.3.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023)
8.3.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034)
8.3.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth 2018-2034
9.2 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type
9.2.1 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023)
9.2.2 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034)
9.2.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
9.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application
9.3.1 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023)
9.3.2 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034)
9.3.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
9.4 APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Novartis Business Overview
10.1.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.1.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.1.5 Novartis Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Details
10.2.2 Gilead Sciences Business Overview
10.2.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.2.4 Gilead Sciences Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.2.5 Gilead Sciences Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Bristol-Myers Squibb Business Overview
10.3.3 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.3.4 Bristol-Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.3.5 Bristol-Myers Squibb Recent Development
10.4 J & J
10.4.1 J & J Company Details
10.4.2 J & J Business Overview
10.4.3 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.4.4 J & J Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.4.5 J & J Recent Development
10.5 JW Therapeutics
10.5.1 JW Therapeutics Company Details
10.5.2 JW Therapeutics Business Overview
10.5.3 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.5.4 JW Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.5.5 JW Therapeutics Recent Development
10.6 FOSUNKite
10.6.1 FOSUNKite Company Details
10.6.2 FOSUNKite Business Overview
10.6.3 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.6.4 FOSUNKite Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.6.5 FOSUNKite Recent Development
10.7 CARsgen Therapeutics
10.7.1 CARsgen Therapeutics Company Details
10.7.2 CARsgen Therapeutics Business Overview
10.7.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.7.4 CARsgen Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.7.5 CARsgen Therapeutics Recent Development
10.8 Autolus Therapeutics
10.8.1 Autolus Therapeutics Company Details
10.8.2 Autolus Therapeutics Business Overview
10.8.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.8.4 Autolus Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.8.5 Autolus Therapeutics Recent Development
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Company Details
10.9.2 Sorrento Therapeutics Business Overview
10.9.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.9.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.9.5 Sorrento Therapeutics Recent Development
10.10 Mustang Bio
10.10.1 Mustang Bio Company Details
10.10.2 Mustang Bio Business Overview
10.10.3 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.10.4 Mustang Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.10.5 Mustang Bio Recent Development
10.11 Bluebird Bio
10.11.1 Bluebird Bio Company Details
10.11.2 Bluebird Bio Business Overview
10.11.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.11.4 Bluebird Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.11.5 Bluebird Bio Recent Development
10.12 Cellectis
10.12.1 Cellectis Company Details
10.12.2 Cellectis Business Overview
10.12.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.12.4 Cellectis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.12.5 Cellectis Recent Development
10.13 Allogene Therapeutics
10.13.1 Allogene Therapeutics Company Details
10.13.2 Allogene Therapeutics Business Overview
10.13.3 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.13.4 Allogene Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.13.5 Allogene Therapeutics Recent Development
10.14 Celyad
10.14.1 Celyad Company Details
10.14.2 Celyad Business Overview
10.14.3 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
10.14.4 Celyad Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
10.14.5 Celyad Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Trends
Table 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers
Table 4. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Challenges
Table 5. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Restraints
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Player, 2018-2023
Table 13. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy as of 2024)
Table 15. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Headquarters and Area Served
Table 16. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Product and Application
Table 17. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 54. Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 59. Gilead Sciences Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Bristol-Myers Squibb Company Details
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 64. Bristol-Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. J & J Company Details
Table 67. J & J Business Overview
Table 68. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 69. J & J Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 70. J & J Recent Development
Table 71. JW Therapeutics Company Details
Table 72. JW Therapeutics Business Overview
Table 73. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 74. JW Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 75. JW Therapeutics Recent Development
Table 76. FOSUNKite Company Details
Table 77. FOSUNKite Business Overview
Table 78. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 79. FOSUNKite Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 80. FOSUNKite Recent Development
Table 81. CARsgen Therapeutics Company Details
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 84. CARsgen Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Development
Table 86. Autolus Therapeutics Company Details
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 89. Autolus Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 90. Autolus Therapeutics Recent Development
Table 91. Sorrento Therapeutics Company Details
Table 92. Sorrento Therapeutics Business Overview
Table 93. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 94. Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 95. Sorrento Therapeutics Recent Development
Table 96. Mustang Bio Company Details
Table 97. Mustang Bio Business Overview
Table 98. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 99. Mustang Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 100. Mustang Bio Recent Development
Table 101. Bluebird Bio Company Details
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 104. Bluebird Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Cellectis Company Details
Table 107. Cellectis Business Overview
Table 108. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 109. Cellectis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 110. Cellectis Recent Development
Table 111. Allogene Therapeutics Company Details
Table 112. Allogene Therapeutics Business Overview
Table 113. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 114. Allogene Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 115. Allogene Therapeutics Recent Development
Table 116. Celyad Company Details
Table 117. Celyad Business Overview
Table 118. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
Table 119. Celyad Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 120. Celyad Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Picture
Figure 2. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size 2018-2034 (US$ Million)
Figure 4. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size 2018-2034 (US$ Million)
Figure 6. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share in Global 2018-2034
Figure 7. Chimeric Antigen Receptor (CAR) T-Cell Therapy Report Years Considered
Figure 8. Product Picture of CD19-targeted
Figure 9. Product Picture of BCMA-targeted
Figure 10. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type in 2024 & 2034
Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
Figure 13. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type in 2024 & 2034
Figure 14. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
Figure 16. Product Picture of Lymphoma
Figure 17. Product Picture of Multiple Myeloma
Figure 18. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application in 2024 & 2034
Figure 19. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2034) & (US$ Million)
Figure 20. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
Figure 21. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application in 2024 & 2034
Figure 22. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2018-2034) & (US$ Million)
Figure 23. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
Figure 24. The Top 5 and 10 Largest Companies of Chimeric Antigen Receptor (CAR) T-Cell Therapy in the World: Market Share by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in 2024
Figure 25. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 26. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Region (2018-2034)
Figure 27. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 28. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
Figure 29. Americas Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
Figure 30. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 31. Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 32. Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 35. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
Figure 36. EMEA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
Figure 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. Middle East Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 41. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
Figure 42. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
Figure 43. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 44. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type (2018-2034)
Figure 45. APAC Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application (2018-2034)
Figure 46. Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 47. South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 48. China Taiwan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. Novartis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 52. Gilead Sciences Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 54. J & J Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 55. JW Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 56. FOSUNKite Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 57. CARsgen Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 58. Autolus Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 59. Sorrento Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 60. Mustang Bio Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 61. Bluebird Bio Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 62. Cellectis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 63. Allogene Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 64. Celyad Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed